FGI-104
FGI-104 is the name of an experimental broad-spectrum antiviral drug, with activity against a range of viruses including Hepatitis B, Hepatitis C, HIV, Ebola virus and Venezuelan equine encephalitis virus. [1]
Mechanism[edit | edit source]
The drug acts by inhibiting the protein TSG101, which transports newly manufactured virions to the exterior of an infected cell, thus breaking the replication cycle of the virus. In pre-clinical studies, FGI-104 has been shown to protect mice from Ebola virus disease.[2]
See also[edit | edit source]
References[edit | edit source]
| Ebolavirus |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marburgvirus |
| ||||||||||||
| Cuevavirus |
| ||||||||||||
| Dianlovirus |
| ||||||||||||
| Striavirus |
| ||||||||||||
| Thamnovirus |
| ||||||||||||
Portions of content adapted from Wikipedia's article on FGI-104 which is released under the CC BY-SA 3.0.
 | This antiinfective drug article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
